HLA-A*0301 & B2M & KRASG12C (VVGACGVGK)
HLA-A*0301 & B2M & KRASG12C (VVGACGVGK) 제품 목록
- 속성
Protein (1)
- 제품 라이브러리
온라인 (1)
- 종
Human (1)
- 태그
His Tag & Avi Tag (1)
- 마커
Biotin-labeled (1)
| 제품 번호 | 종 | 발현 시스템 | 제품 설명 | 단백질 구조 | 순도 | 특성 |
|---|---|---|---|---|---|---|
 Human | HEK293 | Biotinylated Human HLA-A*03:01&B2M&KRASG12C (VVGACGVGK) Complex Protein (Monomer, MALS verified) |  |  |
총 수량1
- 1
HLA-A*0301 & B2M & KRASG12C (VVGACGVGK)분자 배경
The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Biotinylated Human HLA-A*0301 KRASG12C (VVGACGVGK) complex protein is a complex of HLA-A*0301 of the MHC Class I, B2M, and VVGACGVGK peptide of the KRASG12C.
임상 약물 정보
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| ACC-006 | ACC-006 | Phase 2 Clinical | Jiangsu Aidea Pharmaceutical Co Ltd, China Pharmaceutical University | Solid tumours; Carcinoma, Non-Small-Cell Lung | 상세 |
| Sulforadex | SFX-01 | Phase 2 Clinical | Evgen Pharma, Lalilab, Pharmagra Labs Inc | Autistic Disorder; Thrombosis; Precancerous Conditions; Ventricular Dysfunction, Left; Subarachnoid Hemorrhage; Lung Neoplasms; Renal Insufficiency, Chronic; Parkinson Disease; Asthma; Hyperplasia; Prostatic Neoplasms; Carcinoma in Situ; Breast Neoplasms; Head and Neck Neoplasms; Small Cell Lung Carcinoma; Kidney Diseases; Heart Diseases; Neoplasms; Neurodevelopmental Disorders; Nasolabial fold wrinkles; Schizophrenia; Anaplasia; Squamous Cell Carcinoma of Head and Neck; Autism Spectrum Disorder; Drug-Related Side Effects and Adverse Reactions; Heart Failure, Diastolic | 상세 |
| NLM-001 | NLM-001 | Phase 2 Clinical | Nelum Corp | Carcinoma, Pancreatic Ductal | 상세 |
| IMP5471-CA | Phase 1 Clinical | Shanghai Impact Pharmaceutical Co Ltd | Hematologic Diseases | 상세 |
- 제품 목록
- 임상 약물 정보